Laura Ojeda

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.

Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.

Journal: Clinical and translational medicine
Published: December 04, 2024

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy.

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy.

Journal: International journal of molecular sciences
Published: August 21, 2023

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma.

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma.

Journal: International journal of molecular sciences
Published: January 29, 2021

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.

Journal: EBioMedicine
Published: October 09, 2019

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.

Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.

Journal: Cells
Published: June 24, 2019

Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab.

Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab.

Journal: Clinical lung cancer
Published: March 09, 2019

Corrigendum to "Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer".

Corrigendum to "Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer".

Journal: Disease markers
Published: May 07, 2018

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.

Journal: Disease markers
Published: March 31, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026